Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort

Long-term evidence on ustekinumab treatment response and persistence in patients with Crohn’s disease in a real-world setting is scarce. We performed a retrospective nationwide chart review study of long-term clinical outcomes in Crohn’s disease patients treated with ustekinumab. METHODS: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: af Björkesten, Clas-Göran, Ilus, Tuire, Hallinen, Taru, Soini, Erkki, Eberl, Anja, Hakala, Kalle, Heikura, Mikko, Jussila, Airi, Koskela, Ritva, Koskinen, Inka, Moilanen, Veikko, Nielsen, Christian, Nieminen, Urpo, Nuutinen, Heikki, Heikkinen, Markku, Suhonen, Ulla-Maija, Tillonen, Jyrki, Utriainen, Karri, Vihriälä, Ilkka, Wennerström, Christina, Borsi, Andras, Nissinen, Riikka, Koivunen, Minni R., Sipponen, Taina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Original Articles: Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590962/
https://www.ncbi.nlm.nih.gov/pubmed/32868649
http://dx.doi.org/10.1097/MEG.0000000000001831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590962/
https://www.ncbi.nlm.nih.gov/pubmed/32868649
http://dx.doi.org/10.1097/MEG.0000000000001831

Ejemplares similares